Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Gains from Investment Securities (2016 - 2025)

Healthstream (HSTM) has disclosed Gains from Investment Securities for 14 consecutive years, with $90000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities rose 1400.0% to $90000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $90000.0, a 93.62% decrease, with the full-year FY2025 number at $1.3 million, up 1361.11% from a year prior.
  • Gains from Investment Securities was $90000.0 for Q2 2025 at Healthstream, down from $1.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q4 2024 to a low of -$861000.0 in Q3 2024.
  • A 5-year average of $284290.2 and a median of $257000.0 in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 429.89% in 2024, then skyrocketed 1400.0% in 2025.
  • Healthstream's Gains from Investment Securities stood at -$655000.0 in 2021, then soared by 214.2% to $748000.0 in 2022, then tumbled by 61.5% to $288000.0 in 2023, then skyrocketed by 469.1% to $1.6 million in 2024, then crashed by 94.51% to $90000.0 in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Gains from Investment Securities are $90000.0 (Q2 2025), $1.1 million (Q1 2025), and $1.6 million (Q4 2024).